A new study in the Journal of Neurology offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals with early Parkinson's disease (PD). Led by Jamie Adams, M ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Stina Saunders, PhD, Personalized Medicine Lead at Linus Health, will present new data exploring how culturally responsive, person-specific outcome measures can be scaled across international ...

Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and functional impacts evolve for ...

Can our homes help detect brain changes? New research shows how digital sensing reveals subtle shifts in movement and cognition in everyday life, and can track disease progression.

Critical Path Institute applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals ...

The Institute for Clinical and Economic Review (ICER) announced today that it will assess the comparative clinical ...

The "world smells different" for people with Parkinson's disease, a discovery that could help doctors spot the condition sooner ...

Objectives Parkinson’s disease (PD) is a complex, progressive neurological disorder with motor and non-motor symptoms. Among the non-motor symptoms, constipation severely affects the patients’ quality ...

Older adults who require assistance while performing instrumental activities of daily living (IADL) had an increased risk of developing Parkinson’s disease compared to those who did not require ...

Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy was associated with reduced Parkinson disease (PD) risk.

By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...